Eiger Biopharmaceuticals Stock Technical Analysis
As of the 24th of April, Eiger Biopharmaceutica shows the Standard Deviation of 12.45, mean deviation of 6.3, and Variance of 155.06. Eiger Biopharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Eiger Biopharmaceuticals, which can be compared to its peers. Please confirm Eiger Biopharmaceuticals mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Eiger Biopharmaceuticals is priced favorably, providing market reflects its regular price of 0.0 per share.
Eiger Biopharmaceutica Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Eiger, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EigerEiger |
Eiger Biopharmaceutica Analyst Consensus
Target Price | Advice | # of Analysts | |
3.0 | Strong Buy | 1 | Odds |
Most Eiger analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Eiger stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Eiger Biopharmaceuticals, talking to its executives and customers, or listening to Eiger conference calls.
Eiger Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Eiger Biopharmaceuticals Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Eiger Biopharmaceuticals Trend Analysis
Use this graph to draw trend lines for Eiger Biopharmaceuticals. You can use it to identify possible trend reversals for Eiger Biopharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Eiger Biopharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Eiger Biopharmaceutica Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Eiger Biopharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.07 , which may suggest that Eiger Biopharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 189.79, which is the sum of squared deviations for the predicted Eiger Biopharmaceutica price change compared to its average price change.About Eiger Biopharmaceutica Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Eiger Biopharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Eiger Biopharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Eiger Biopharmaceuticals price pattern first instead of the macroeconomic environment surrounding Eiger Biopharmaceuticals. By analyzing Eiger Biopharmaceutica's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Eiger Biopharmaceutica's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Eiger Biopharmaceutica specific price patterns or momentum indicators. Please read more on our technical analysis page.
2010 | 2023 | 2024 (projected) | Dividend Yield | 1.97E-4 | 3.45E-4 | 2.32E-4 | Price To Sales Ratio | 14.51 | 0.63 | 0.6 |
Eiger Biopharmaceutica April 24, 2024 Technical Indicators
Most technical analysis of Eiger help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Eiger from various momentum indicators to cycle indicators. When you analyze Eiger charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.03) | |||
Market Risk Adjusted Performance | (0.65) | |||
Mean Deviation | 6.3 | |||
Coefficient Of Variation | (1,669) | |||
Standard Deviation | 12.45 | |||
Variance | 155.06 | |||
Information Ratio | (0.07) | |||
Jensen Alpha | (0.85) | |||
Total Risk Alpha | (2.46) | |||
Treynor Ratio | (0.66) | |||
Maximum Drawdown | 97.26 | |||
Value At Risk | (11.17) | |||
Potential Upside | 18.5 | |||
Skewness | (2.17) | |||
Kurtosis | 17.58 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Eiger Biopharmaceuticals information on this page should be used as a complementary analysis to other Eiger Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Eiger Stock analysis
When running Eiger Biopharmaceutica's price analysis, check to measure Eiger Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eiger Biopharmaceutica is operating at the current time. Most of Eiger Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Eiger Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eiger Biopharmaceutica's price. Additionally, you may evaluate how the addition of Eiger Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Eiger Biopharmaceutica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eiger Biopharmaceutica. If investors know Eiger will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eiger Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (58.50) | Revenue Per Share 9.951 | Quarterly Revenue Growth (0.20) | Return On Assets (0.52) | Return On Equity (2.26) |
The market value of Eiger Biopharmaceuticals is measured differently than its book value, which is the value of Eiger that is recorded on the company's balance sheet. Investors also form their own opinion of Eiger Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Eiger Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eiger Biopharmaceutica's market value can be influenced by many factors that don't directly affect Eiger Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eiger Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eiger Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eiger Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.